1. Aminoglutethimide enzyme induction: pharmacological and endocrinological implications

   • Per Eystein Lønning

   Review Pages: 241 - 244

2. In vitro sensitivity testing of human breast cancer cells to hormones and chemotherapeutic agents

   • J. T. Emerman
   • A. W. Tolcher
   • P. M. Rebbeck

   OriginalPaper Pages: 245 - 249

3. Patterns of cross-resistance in a multidrug-resistant small-cell lung carcinoma cell line

   • S. P. C. Cole

   OriginalPaper Pages: 250 - 256

4. A DNA topoisomerase II-independent route for novobiocin-mediated resistance to DNA binding agents

   • Paul J. Smith
   • Sandra M. Bell

   OriginalPaper Pages: 257 - 262

5. Brain uptake and anticancer activities of vincristine and vinblastine are restricted by their low cerebrovascular permeability and binding to plasma constituents in rat

   • Nigel H. Greig
   • Timothy T. Soncrant
   • Stanley I. Rapoport

   OriginalPaper Pages: 263 - 268

6. Combined effect of pH and sodium cyanate on the inhibition of tumor cell proliferation and metabolism by BCNU and hyperthermia

   • Jennifer J. Hu
   • Karimullah A. Zirvi
   • Michael A. Lea

   OriginalPaper Pages: 269 - 272

7. Inhibition of thymidylate synthase by the diastereoisomers of leucovorin

   • Pauline P. Lee
   • Richard L. Schilsky

   OriginalPaper Pages: 273 - 277

8. Influence of hydration on ultrafilterable platinum kinetics and kidney function in patients treated withcis-diamminedichloroplatinum(II)

   • Monique Dumas
   • Catherine de Gislain
   • Nicole Autissier

   OriginalPaper Pages: 278 - 282

9. Phase I and pharmacokinetic study of intraperitoneal thioTEPA in patients with ovarian cancer

   • Craig Lewis
   • Nora Lawson
   • Stanley B. Kaye

   OriginalPaper Pages: 283 - 287

10. 6-Thioguanine nucleotide accumulation in red blood cells during maintenance chemotherapy for childhood acute lymphoblastic leukemia, and its relation to leukopenia

    • Kjeld Schmiegelow
    • Ivan Bruunshuus

    OriginalPaper Pages: 288 - 292

11. 4′-O-Tetrahydropyranyl-doxorubicin in advanced breast cancer: a phase II study

    • Hellmut Samonigg
    • Anne-Katrin Kasparek
    • Peter Lechner

    OriginalPaper Pages: 293 - 296

12. Good tolerance of weekly oral idarubicin: (4-demethoxydaunorubicin): A phase I study with pharmacology

    • Howard Hochster
    • Michael Green
    • Franco Muggia

    OriginalPaper Pages: 297 - 300

13. An effective oral combination in advanced relapsed Hodgkin’s disease prednisolone, etoposide, chlorambucil and CCNU

    • Anne L. Lennard
    • Peter J. Carey
    • Stephen J. Proctor

    OriginalPaper Pages: 301 - 305

14. Treatment of resistant non-Hodgkin’s lymphomas with cisplatin, etoposide, and bleomycin

    • Pasquale Comella
    • Giuseppe Abate
    • Donato Zarrilli

    Short Communication Pages: 306 - 309

15. Interaction of antiestrogens with binding sites for muscarinic cholinergic drugs and calcium channel blockers in cell membranes

    • Satish Batra

    Short Communication Pages: 310 - 312